JP Morgan Chase pushes use of credit derivatives to enhance returns

JP Morgan Chase plans to give a number of presentations to asset managers to encourage them to use credit derivatives to enhance returns.

Matt King, in charge of European credit strategy at JP Morgan in London, said he will give the first presentation in Poland on Thursday, then to clients in London beginning on Friday. His main focus will be on the vanilla asset manager community, who are "just beginning to realise that they have the most need for it”, King said.

JP Morgan believes cash credit managers are barely making any money, but that this is more to do with constraints on their trading than with their investment skills. King will argue that only through the use of credit default swaps (CDSs) and collateralised debt obligations (CDOs) can they hope to control their risks while investing in credit. “The asymmetric return distribution in credit means they risk losing much more from a single blow-up than they can ever hope to make by avoiding them,” said King.

King added that more cash portfolio managers are turning to JP Morgan to ask for help “gaining permission” to use credit derivatives, either in the form of CDSs or CDOs.

“Illiquidity of the cash market leaves portfolio managers struggling simply to earn carry as the source of their profits. This may be sufficient in a bull market, but is disastrous when spreads are widening,” King said.

But a number of banks, such as Italy's IntesaBCI, and insurers/reinsurers - for example, France's Scor - have cut back or suspended further investments in vanilla and exotic credit derivatives products during the past three months.

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

Most read articles loading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here